Clinical Trial Update: D-Cycloserine and Virtual Reality Exposure Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial combining D-Cycloserine with Virtual Reality Exposure Therapy for Social Anxiety Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Georgia State University | Conditions: Social Anxiety Disorder | Phase 2 | Status: WITHDRAWN